Olga Hamming‐Vrieze

2.0k total citations
60 papers, 1.4k citations indexed

About

Olga Hamming‐Vrieze is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Olga Hamming‐Vrieze has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Otorhinolaryngology, 28 papers in Pulmonary and Respiratory Medicine and 19 papers in Radiation. Recurrent topics in Olga Hamming‐Vrieze's work include Head and Neck Cancer Studies (40 papers), Advanced Radiotherapy Techniques (19 papers) and Head and Neck Surgical Oncology (12 papers). Olga Hamming‐Vrieze is often cited by papers focused on Head and Neck Cancer Studies (40 papers), Advanced Radiotherapy Techniques (19 papers) and Head and Neck Surgical Oncology (12 papers). Olga Hamming‐Vrieze collaborates with scholars based in Netherlands, United Kingdom and United States. Olga Hamming‐Vrieze's co-authors include Michiel W. M. van den Brekel, Frans J. M. Hilgers, Lisette van der Molen, Sophie A. C. Kraaijenga, Jan‐Jakob Sonke, Adriana J. Timmermans, Frank Hoebers, Arash Navran, Wouter V. Vogel and Marcel van Herk and has published in prestigious journals such as PLoS ONE, International Journal of Radiation Oncology*Biology*Physics and Physics in Medicine and Biology.

In The Last Decade

Olga Hamming‐Vrieze

56 papers receiving 1.3k citations

Peers

Countries citing papers authored by Olga Hamming‐Vrieze

Since Specialization

Citations

This map shows the geographic impact of Olga Hamming‐Vrieze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Hamming‐Vrieze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Hamming‐Vrieze more than expected).

Fields of papers citing papers by Olga Hamming‐Vrieze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Hamming‐Vrieze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Hamming‐Vrieze. The network helps show where Olga Hamming‐Vrieze may publish in the future.

Co-authorship network of co-authors of Olga Hamming‐Vrieze

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Hamming‐Vrieze. A scholar is included among the top collaborators of Olga Hamming‐Vrieze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Hamming‐Vrieze. Olga Hamming‐Vrieze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Introduction of Stem Cell Sparing Radiotherapy to Reduce the Risk of Xerostomia in Patients with Head and Neck Cancer 2024 ·Cancers ·(unknown), A. van der Schaaf, (unknown), (unknown), Rachel Ger, Olga Hamming‐Vrieze, Frank Hoebers, Mischa de Ridder, S. Vigorito, (unknown), Johannes A. Langendijk, Peter van Luijk, R.J.H.M. Steenbakkers	0
2	A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE) 2024 ·Radiotherapy and Oncology ·(unknown), J. Giralt, Yungan Tao, Sergi Benavente, (unknown), Frank Hoebers, Ann Hoeben, Chris H.J. Terhaard, (unknown), Signe Friesland, Roel J.H.M. Steenbakkers, Lisa Tans, Jolien Heukelom, (unknown), Simon van Kranen, Harry Bartelink, C. Rasch, Jan‐Jakob Sonke, Olga Hamming‐Vrieze	5
3	Comparisons of normal tissue complication probability models derived from planned and delivered dose for head and neck cancer patients 2021 ·Radiotherapy and Oncology ·(unknown), Simon van Kranen, (unknown), Olga Hamming‐Vrieze, Abrahim Al‐Mamgani, Jan‐Jakob Sonke	2
4	Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes 2021 ·Radiotherapy and Oncology ·Abrahim Al‐Mamgani, Rob Kessels, Arash Navran, Olga Hamming‐Vrieze, Charlotte L. Zuur, Jan Paul de Boer, (unknown), Tomas Janssen, Jan‐Jakob Sonke, Corrie A.M. Marijnen	9
5	Postoperative radiotherapy in stage I–III Merkel cell carcinoma 2021 ·Radiotherapy and Oncology ·(unknown), (unknown), Dirk J. Grünhagen, Mathilde Jalving, Olga Hamming‐Vrieze, Lukas B. Been, Lisa Tans, Alexander C. J. van Akkooi, Margot Tesselaar	6
6	[18F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials 2020 ·Clinical and Translational Radiation Oncology ·Sebastian Sanduleanu, Olga Hamming‐Vrieze, Frederik Wesseling, Aniek J.G. Even, Frank Hoebers, Ann Hoeben, Wouter V. Vogel, Margot Tesselaar, (unknown), Harry Bartelink, Philippe Lambin	16
7	Protocolised way to cope with anatomical changes in head & neck cancer during the course of radiotherapy 2019 ·Technical Innovations & Patient Support in Radiation Oncology ·Suzanne van Beek, (unknown), Olga Hamming‐Vrieze, Abrahim Al‐Mamgani, Arash Navran, P. Remeijer, Jeroen B. van de Kamer	18
8	FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation 2019 ·European Archives of Oto-Rhino-Laryngology ·Mischa de Ridder, (unknown), Arash Navran, Olga Hamming‐Vrieze, Bas Jasperse, Michiel W. M. van den Brekel, Wouter V. Vogel, Abrahim Al‐Mamgani	6
9	Biological PET-guided adaptive radiotherapy for dose escalation in head and neck cancer: a systematic review 2018 ·The Quarterly Journal of Nuclear Medicine and Molecular Imaging ·Olga Hamming‐Vrieze, Arash Navran, Abrahim Al‐Mamgani, Wouter V. Vogel	14
10	The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT) 2018 ·Radiotherapy and Oncology ·Arash Navran, Wilma D. Heemsbergen, Tomas Janssen, Olga Hamming‐Vrieze, (unknown), Charlotte L. Zuur, Marcel Verheij, P. Remeijer, Jan‐Jakob Sonke, Michiel W. M. van den Brekel, Abrahim Al‐Mamgani	65
11	SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models 2018 ·Radiotherapy and Oncology ·(unknown), Tomas Janssen, (unknown), (unknown), Olga Hamming‐Vrieze, Wouter V. Vogel, Jan‐Jakob Sonke, Abrahim Al‐Mamgani	15
12	A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response 2017 ·Clinical and Translational Radiation Oncology ·(unknown), Bas Jasperse, Jan‐Jakob Sonke, Wilma D. Heemsbergen, Arash Navran, Olga Hamming‐Vrieze, Jan Paul de Boer, Michiel W. M. van den Brekel, Abrahim Al‐Mamgani	5
13	Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: A literature-based critical review 2017 ·Cancer Treatment Reviews ·Abrahim Al‐Mamgani, Erik van Werkhoven, Arash Navran, Baris Karakullukçu, Olga Hamming‐Vrieze, (unknown), Lilly‐Ann van der Velden, Wouter V. Vogel, W. Martin C. Klop	45
14	Orthovoltage for basal cell carcinoma of the head and neck: Excellent local control and low toxicity profile 2016 ·The Laryngoscope ·(unknown), Peter J. F. M. Lohuis, Wilma D. Heemsbergen, (unknown), Arash Navran, Olga Hamming‐Vrieze, W. Martin C. Klop, (unknown), Abrahim Al‐Mamgani	8
15	Orthovoltage X-rays for Postoperative Treatment of Resected Basal Cell Carcinoma in the Head and Neck Area 2016 ·Journal of Cutaneous Medicine and Surgery ·(unknown), Peter J. F. M. Lohuis, Marianne B. Crijns, Arash Navran, Rick L. Haas, Olga Hamming‐Vrieze, W. Martin C. Klop, Michiel W. M. van den Brekel, Abrahim Al‐Mamgani	8
16	Assessment of voice, speech, and related quality of life in advanced head and neck cancer patients 10-years+ after chemoradiotherapy 2016 ·Oral Oncology ·Sophie A. C. Kraaijenga, (unknown), R.J.J.H. van Son, Olga Hamming‐Vrieze, Frans J. M. Hilgers, Michiel W. M. van den Brekel, Lisette van der Molen	52
17	Cause-specific excess mortality in patients treated for cancer of the oral cavity and oropharynx: A population-based study 2015 ·Oral Oncology ·(unknown), Michael Schaapveld, Olga Hamming‐Vrieze, Jan Paul de Boer, Michiel W. M. van den Brekel, A.J.M. Balm	13
18	Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises 2014 ·European Archives of Oto-Rhino-Laryngology ·Sophie A. C. Kraaijenga, Lisette van der Molen, Irene Jacobi, Olga Hamming‐Vrieze, Frans J. M. Hilgers, Michiel W. M. van den Brekel	78
19	Evaluation of Tumor Shape Variability in Head-and-Neck Cancer Patients Over the Course of Radiation Therapy Using Implanted Gold Markers 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Olga Hamming‐Vrieze, Simon van Kranen, Suzanne van Beek, Wilma D. Heemsbergen, Marcel van Herk, Michiel W. M. van den Brekel, Jan‐Jakob Sonke, C. Rasch	15
20	mTHPC mediated interstitial photodynamic therapy of recurrent nonmetastatic base of tongue cancers: Development of a new method 2012 ·Head & Neck ·Barış Karakullukçu, (unknown), (unknown), Frank Hoebers, Olga Hamming‐Vrieze, Max J. H. Witjes, Sebastiaan A. H. J. de Visscher, Fred R. Burlage, Peter C. Levendag, Henricus J. C. M. Sterenborg, I. Bing Tan	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact